Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • ESG
  • News & Media
  • Contact
  • Menu Menu

UCAM LifeTech Summit Awards Gate2Brain for Its Impact

Funding & Breakthroughs, News, timeline

The third edition of the LifeTech Summit, organized by UCAM HiTech, the UCAM innovation and business acceleration hub and part of the INCYDE Foundation’s High-Tech Incubator Network, has closed its pitch competition by awarding two startups from the Spanish scientific ecosystem for their investment attraction potential and the social impact of their solutions. Each startup received a prize worth 2,000 euros: Trak and Gate2Brain.

The awards were made possible thanks to the support of Telefónica and the sponsorship of Letslaw, Cinfa, Info Región de Murcia, H&A, Caixabank, CMG MedDev, and Grupo Orenes, entities firmly committed to science-based entrepreneurship as a driver of innovation and economic development. The awards were presented by Samuel Rabadán, Director of DayOne for the Valencian Community and Murcia Region at Caixabank, and María José Bernal, Head of Business Development at Info.

Recognition of science that interests investors

The jury evaluated ten seed-stage projects, many of them emerging from universities, hospitals, and research centers, reaffirming the growing appeal of deep tech startups and the biotech and medical device sectors.

The most investable startup, awarded for its scalability potential and technological maturity, was Trak, represented by Jaime Rodríguez, which offers a personalized digital rehabilitation solution using artificial intelligence. Its platform improves therapeutic adherence, reduces costs, and enables personalized clinical monitoring from anywhere, making it a highly efficient tool for healthcare systems and insurers.

Meanwhile, the award for the startup with the greatest impact went to Gate2Brain, represented by Meritxell Teixidó, for its shuttle peptide technology that facilitates the transport of drugs to the brain, opening new therapeutic avenues for diseases such as childhood brain tumors.

Murcia’s healthcare system in search of disruptive technologies

During the LifeTech Summit, representatives from the Murcia Health Service, the Virgen de la Arrixaca Hospital, and Ribera Salud held meetings with ten scientific startups with high potential for clinical application: Teraomics, Ainovis, Gennetika, MATCH Biosystems, Heuristik, Trak, Ownmed Innovation, Limbium, Vasomaly, and Corsonic.

The proposals presented addressed key challenges facing the healthcare system, such as the early diagnosis of complex diseases, the automation of clinical processes, patient tracking, improved physical rehabilitation, advanced vascular analysis, solutions for people with ostomies or amputees, and the use of artificial intelligence in radiology and cardiology. This interaction between startups and hospitals reflects the Murcia healthcare ecosystem’s commitment to identifying emerging technologies and has opened up opportunities for collaboration on projects with high potential to improve clinical care and positively impact patients’ lives.

Transfer as a Driver of Growth

According to the Report on Healthcare Entrepreneurship in Spain, more than 80% of the most successful spin-offs in the sector originate in academic settings, but only those capable of clinically validating their solutions and connecting with investors from an early stage manage to scale.

The LifeTech Summit responds to this challenge by connecting science, capital, and talent. In this edition, more than 100 technology-based startups—60% linked to the healthcare sector and 80% in the seed phase—held meetings with more than 100 funds, corporations, and entities in an environment that surpassed last year’s figure of 1,000 meetings, consolidating its position as one of the most active investment forums in applied science in the country. Among the developments presented were digital rehabilitation platforms with AI, real-time immunological diagnostics, clinical biometrics for hospital traceability, and digital therapies for chronic diseases.

This connected environment is reinforced by initiatives such as the scientific entrepreneurship community, Coral (www.thecoral.net), which already brings together more than 1,000 scientists and entrepreneurs committed to bringing science to market.

With this approach, the LifeTech Summit not only rewards projects but also reaffirms its role as a catalyst between science and investment, contributing to the positioning of the Region of Murcia as a hub for innovation in healthcare, biotechnology, and medical technology.

Murcia Diario

May 27, 2025/by noticias
Tags: UCAM LifeTech Summit
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2025/05/Murcia.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2025-05-27 12:01:262025-10-14 07:40:25UCAM LifeTech Summit Awards Gate2Brain for Its Impact

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Gate2Brain turns 5!July 9, 2025 - 18:07
  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Spain & India, working in the clinical development for a novel therapy...Gate2Brain arrives at Alhambra Venture with technology that crosses the brain...
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}